フランスのジェネリック医薬品の業界プロファイルでは、セクターの規模(2017〜2022 年の価値と量、および 2027 年までの予測)などの主要な定性的および定量的概要情報が提供されます。 プロファイルには、主要な財務指標やセクター内の競争圧力の分析など、主要企業の説明も含まれています。
						目次
						
	Table of Contents
	1 Executive Summary
	
	1.1. Market value
	1.2. Market value forecast
	1.3. Market volume
	1.4. Market volume forecast
	1.5. Geography segmentation
	1.6. Market rivalry
	1.7. Competitive landscape
	2 Market Overview
	
	2.1. Market definition
	2.2. Market analysis
	3 Market Data
	
	3.1. Market value
	3.2. Market volume
	4 Market Segmentation
	
	4.1. Geography segmentation
	5 Market Outlook
	
	5.1. Market value forecast
	5.2. Market volume forecast
	6 Five Forces Analysis
	
	6.1. Summary
	6.2. Buyer power
	6.3. Supplier power
	6.4. New entrants
	6.5. Threat of substitutes
	6.6. Degree of rivalry
	7 Competitive Landscape
	
	7.1. Who are the leading players?
	7.2. What are the strengths of the leading players?
	7.3. Have there been any recent developments in the market?
	8 Company Profiles
	
	8.1. Teva Pharmaceutical Industries Limited
	8.2. Pfizer Inc.
	8.3. Sanofi SA
	8.4. Les Laboratoires Servier
	9 Macroeconomic Indicators
	
	9.1. Country data
	10 Appendix
	
	10.1. Methodology
	10.2. Industry associations
	10.3. Related MarketLine research
	10.4. About MarketLine
	List of Tables
	
	Table 1: France generics market value: $ million, 2017-22
	Table 2: France generics market volume: %, 2017-22
	Table 3: France generics market geography segmentation: $ million, 2022
	Table 4: France generics market value forecast: $ million, 2022-27
	Table 5: France generics market volume forecast: %, 2022-27
	Table 6: Teva Pharmaceutical Industries Limited: key facts
	Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
	Table 8: Teva Pharmaceutical Industries Limited: Key Employees
	Table 9: Pfizer Inc.: key facts
	Table 10: Pfizer Inc.: Annual Financial Ratios
	Table 11: Pfizer Inc.: Key Employees
	Table 12: Pfizer Inc.: Key Employees Continued
	Table 13: Sanofi SA: key facts
	Table 14: Sanofi SA: Annual Financial Ratios
	Table 15: Sanofi SA: Key Employees
	Table 16: Sanofi SA: Key Employees Continued
	Table 17: Les Laboratoires Servier: key facts
	Table 18: Les Laboratoires Servier: Key Employees
	Table 19: France size of population (million), 2018-22
	Table 20: France gdp (constant 2005 prices, $ billion), 2018-22
	Table 21: France gdp (current prices, $ billion), 2018-22
	Table 22: France inflation, 2018-22
	Table 23: France consumer price index (absolute), 2018-22
	Table 24: France exchange rate, 2018-22
	List of Figures
	
	Figure 1: France generics market value: $ million, 2017-22
	Figure 2: France generics market volume: %, 2017-22
	Figure 3: France generics market geography segmentation: % share, by value, 2022
	Figure 4: France generics market value forecast: $ million, 2022-27
	Figure 5: France generics market volume forecast: %, 2022-27
	Figure 6: Forces driving competition in the generics market in France, 2022
	Figure 7: Drivers of buyer power in the generics market in France, 2022
	Figure 8: Drivers of supplier power in the generics market in France, 2022
	Figure 9: Factors influencing the likelihood of new entrants in the generics market in France, 2022
	Figure 10: Factors influencing the threat of substitutes in the generics market in France, 2022
	Figure 11: Drivers of degree of rivalry in the generics market in France, 2022